Clinical Trials Information System (CTIS) bitesize talk: Training materials, CTIS pre-requisites, and updates on transparency rules

Latvian is available via eTranslation, the European Commission's machine translation service.

Translate to Latvian | Important information about machine translation

Date

Trešdiena, 29 Novembris 2023, Visu dienu

Vieta

Online
European Medicines Agency, Amsterdam, the Netherlands

Event summary

CTIS is the business tool of the EU Clinical Trials Regulation (Regulation (EU) No 536/2014) and it acts as a single entry point for clinical trial authorisation and supervision in the European Economic Area.

This bitesize talk on CTIS aims to provide sponsors with a reminder on the CTIS training materials, the prerequisites for sponsors before using CTIS, and the updates on the transparency rules. Sponsors will also have the opportunity to ask questions on this CTIS topic before the event.

The event is open to all sponsor organisations, including pharmaceutical companies, contract research organisations, small and medium-sized enterprises (SMEs) and academic organisations. EMA cannot provide attendees certificates of attendance for this event.

To be better prepared for this event, sponsors are encouraged to consult the CTIS training and support materials:

Documents

Video recording

Share this page